Explore more publications!
Technology Times New Jersey
Submit Press Release

Technology Times New Jersey: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 31, 2025

Surfshark protects against phishing attacks with the email scam checker
October 31, 2025

Surfshark protects against phishing attacks with the email scam checker

Indeterminate GlobeNewswire
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
October 31, 2025

Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Indeterminate GlobeNewswire
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
October 31, 2025

HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead

Indeterminate GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
October 31, 2025

Certara to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Alps Announces Closing of Business Combination with Globalink Investment Inc.
October 31, 2025

Alps Announces Closing of Business Combination with Globalink Investment Inc.

Indeterminate GlobeNewswire
Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy
October 31, 2025

Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy

Indeterminate GlobeNewswire
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
October 31, 2025

Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire
TappAlpha’s TDAQ Surpasses $25 Million AUM in Under Two Months, Outpacing Nasdaq 100 in Performance
October 31, 2025

TappAlpha’s TDAQ Surpasses $25 Million AUM in Under Two Months, Outpacing Nasdaq 100 in Performance

Indeterminate GlobeNewswire
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
October 31, 2025

TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update

Indeterminate GlobeNewswire
Acorn, Provider of Monitoring and Control Solutions for Power Generators, Hosts Q3 Earnings Call Thursday Nov. 6th at 11am ET
October 31, 2025

Acorn, Provider of Monitoring and Control Solutions for Power Generators, Hosts Q3 Earnings Call Thursday Nov. 6th at 11am ET

Indeterminate GlobeNewswire
Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
October 31, 2025

Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report

Indeterminate GlobeNewswire
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
October 31, 2025

Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Indeterminate GlobeNewswire
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
October 31, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025

Indeterminate GlobeNewswire
BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
October 31, 2025

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers

Indeterminate GlobeNewswire
Upstream Bio to Participate in Upcoming November Investor Conferences
October 31, 2025

Upstream Bio to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire
Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award
October 31, 2025

Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award

Indeterminate GlobeNewswire
Castellum, Inc. Announces the Award of a $66.2 million Full and Open Contract to its SSI Subsidiary
October 31, 2025

Castellum, Inc. Announces the Award of a $66.2 million Full and Open Contract to its SSI Subsidiary

Indeterminate GlobeNewswire
Immuron Announces Clinical Trial Update
October 31, 2025

Immuron Announces Clinical Trial Update

Indeterminate GlobeNewswire
Aurora Mobile Partners with Tuniu to Enhance Travel Experience with JPush Intelligent Messaging
October 31, 2025

Aurora Mobile Partners with Tuniu to Enhance Travel Experience with JPush Intelligent Messaging

Indeterminate GlobeNewswire
Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong
October 31, 2025

Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions